Codexis Inc. (CDXS) Stock: What the Analysts are Saying

The stock has a 36-month beta value of 2.08. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”

The public float for CDXS is 67.52M, and at present, short sellers hold a 3.52% of that float. On May 06, 2024, the average trading volume of CDXS was 574.74K shares.

CDXS) stock’s latest price update

Codexis Inc. (NASDAQ: CDXS)’s stock price has soared by 17.37 in relation to previous closing price of 3.34. Nevertheless, the company has seen a gain of 47.37% in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-18 that REDWOOD CITY, Calif., April 18, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first quarter of 2024 on Thursday, May 2, 2024, following the close of market. Codexis management will host a conference call and webcast at 4:30 pm Eastern Time to discuss the Company’s financial results and provide a business update.

CDXS’s Market Performance

Codexis Inc. (CDXS) has seen a 47.37% rise in stock performance for the week, with a 22.12% gain in the past month and a 44.12% surge in the past quarter. The volatility ratio for the week is 10.89%, and the volatility levels for the past 30 days are at 6.81% for CDXS. The simple moving average for the past 20 days is 33.27% for CDXS’s stock, with a 52.25% simple moving average for the past 200 days.

Analysts’ Opinion of CDXS

TD Cowen gave a rating of “Market Perform” to CDXS, setting the target price at $4 in the report published on August 07th of the previous year.

CDXS Trading at 18.79% from the 50-Day Moving Average

After a stumble in the market that brought CDXS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.16% of loss for the given period.

Volatility was left at 6.81%, however, over the last 30 days, the volatility rate increased by 10.89%, as shares surge +22.88% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +36.59% upper at present.

During the last 5 trading sessions, CDXS rose by +47.37%, which changed the moving average for the period of 200-days by +14.62% in comparison to the 20-day moving average, which settled at $2.98. In addition, Codexis Inc. saw 28.52% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CDXS starting from Dorgan Byron L, who sale 20,000 shares at the price of $2.11 back on Nov 15 ’23. After this action, Dorgan Byron L now owns 193,461 shares of Codexis Inc., valued at $42,168 using the latest closing price.

Norrett Kevin, the Chief Operating Officer of Codexis Inc., purchase 9,000 shares at $1.72 during a trade that took place back on Sep 11 ’23, which means that Norrett Kevin is holding 98,102 shares at $15,479 based on the most recent closing price.

Stock Fundamentals for CDXS

Current profitability levels for the company are sitting at:

  • -0.76 for the present operating margin
  • 0.79 for the gross margin

The net margin for Codexis Inc. stands at -0.88. The total capital return value is set at -0.47. Equity return is now at value -63.45, with -35.43 for asset returns.

Based on Codexis Inc. (CDXS), the company’s capital structure generated 0.29 points at debt to capital in total, while cash flow to debt ratio is standing at -1.6.

Currently, EBITDA for the company is -44.88 million with net debt to EBITDA at 0.66. When we switch over and look at the enterprise to sales, we see a ratio of 3.52. The receivables turnover for the company is 5.23for trailing twelve months and the total asset turnover is 0.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.71.

Conclusion

To sum up, Codexis Inc. (CDXS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts